This is a condition where your body stores too much iron, especially in the liver and certain blood cells. It's like having too much iron build-up in your tissues. The iron builds up into a substance called hemosiderin.
Every report comes from a Lived member, sent anonymously.
Have you tried Deferasirox for Hemosiderosis?
Hemosiderosis means that iron has built up in body tissues as hemosiderin, the form in which the body stores excess iron. The word describes where iron has collected rather than naming one disease, so what it means for a person depends on where the iron is and why it got there. The most common form is body-wide iron overload in people who need repeated blood transfusions, often called transfusional hemosiderosis or transfusional iron overload. Over months to years, the extra iron settles in the liver, the heart and the hormone-producing glands. It usually causes no symptoms at first, but if it keeps building it can gradually damage those organs, which is why people on regular transfusions are checked for it. Iron can also collect in one place after repeated bleeding there. In pulmonary hemosiderosis, bleeding into the tiny air sacs of the lungs leaves iron behind. Its best-known form, idiopathic pulmonary hemosiderosis (idiopathic means the cause is unknown), is rare, mostly affects children and causes cough, coughing up blood, breathlessness and iron-deficiency anemia. Superficial siderosis is a rare form in which slow bleeding leaves iron on the surface of the brain and spinal cord, typically causing unsteady walking and hearing loss. Hemosiderosis is related to, but different from, hereditary hemochromatosis, an inherited condition in which the body absorbs too much iron from food.
The body has no active way to get rid of extra iron. It normally absorbs and loses only about 1 milligram a day, through shed skin and cells, sweat and menstrual bleeding. Each unit of transfused blood carries roughly 200 to 250 milligrams of iron, so people who need many transfusions take in iron far faster than they can lose it, and the excess accumulates. Those most at risk depend on regular transfusions for anemias that are not caused by iron deficiency, such as thalassemia major, sickle cell disease, myelodysplastic syndromes (bone marrow disorders that produce too few healthy blood cells) and aplastic anemia (a failure of the bone marrow to make enough blood cells). The number of units received is the main driver: the more transfusions, the more iron. Ongoing breakdown of red blood cells (hemolysis) and, less often, very high iron intake can add to the load. People who receive many transfusions during cancer treatment or a stem cell transplant can also end up with iron overload after treatment ends. The localized forms have different causes. Idiopathic pulmonary hemosiderosis is thought to be driven by the immune system, and some people with it also have celiac disease. Bleeding into the lungs can also come from other illnesses, such as autoimmune conditions that inflame small blood vessels, which is why those are looked for first. Superficial siderosis usually results from a slow, often unnoticed bleed, commonly from a small tear in the membrane that surrounds the spinal cord, or after head injury or brain or spinal surgery. In older adults, a different surface pattern linked to fragile blood vessels in the brain (cerebral amyloid angiopathy) is common and is assessed differently.
For body-wide iron overload, the first clues usually come from blood tests. Ferritin is a protein that stores iron, and its level in the blood rises as iron stores grow, so it is used to follow the trend over time. Transferrin saturation shows how much of the main iron-carrying protein in the blood is already loaded with iron. Ferritin is an imperfect guide on its own, because infection, inflammation and liver problems can raise it even when iron stores have not changed. For that reason, MRI is used to measure iron in the organs themselves without a biopsy. A liver MRI estimates how much iron the liver holds, and a cardiac T2* MRI (said "T2 star") detects iron in the heart muscle. Because iron builds up in and leaves different organs at different rates, the two scans answer different questions. Clinicians also check how well the liver, heart and hormone glands are working, to look for effects of the iron. Pulmonary hemosiderosis is suspected when someone has repeated episodes of cough, breathlessness or coughing up blood, shadows on chest imaging, and iron-deficiency anemia that has no other explanation. Children often do not cough up blood, so unexplained anemia can be the main clue. Assessment usually includes chest X-ray or CT, blood counts and antibody tests, and bronchoscopy, in which a thin scope is passed into the airways to wash out and examine fluid from the lungs. A lung biopsy is sometimes needed. Idiopathic pulmonary hemosiderosis is diagnosed only after infections, autoimmune diseases and other causes of lung bleeding have been ruled out. Superficial siderosis is diagnosed on MRI using sequences that are especially sensitive to iron deposits.
For transfusional iron overload, the main treatment is iron chelation: medicines that bind iron so the body can pass it out. Starting chelation before iron reaches harmful levels can prevent its most serious complications, and effective chelation combined with MRI monitoring has greatly reduced the harm iron causes in people with transfusion-dependent anemias. Three chelators are used in the US. Deferoxamine (Desferal) is given as a slow infusion under the skin, usually over 8 to 12 hours overnight with a small portable pump, 5 to 7 nights a week. It is effective, but the schedule is demanding. Deferasirox (Exjade and other formulations) is taken by mouth once a day and is approved from age 2. Deferiprone (Ferriprox) is taken by mouth as tablets (approved from age 8) or a liquid (approved from age 3), for people with thalassemia, sickle cell disease or other anemias. The choice depends on age, which organs hold the most iron, side effects and what someone can realistically keep up with. Each chelator needs regular blood tests. Deferasirox can injure the kidneys and liver, so kidney and liver function are checked at least monthly. Deferiprone can cause a sudden, severe drop in infection-fighting white blood cells, so blood counts are checked regularly and signs of infection need to be reported right away. Doses are adjusted as iron levels fall, because too much chelation also causes problems. When transfusions are no longer needed and blood counts have recovered, for example after a successful stem cell transplant, regularly removing blood (phlebotomy) can be used instead to draw down stored iron. Pulmonary hemosiderosis is treated differently, because the problem is bleeding in the lungs rather than too much iron overall. There is no single standard regimen. Corticosteroids (steroid medicines that calm inflammation) are usually the first treatment and can help control bleeding and limit later scarring. Other immune-suppressing medicines, such as azathioprine, hydroxychloroquine or rituximab, may be added, particularly to reduce long-term steroid use. Transfusions can correct severe anemia. In people who also have celiac disease, a strict gluten-free diet has often improved the lung disease. Severe bleeding may need intensive care, and lung transplant is a last resort. Superficial siderosis is managed by neurology and neurosurgery specialists, beginning with a search for the source of bleeding.
For people who need long-term transfusions, managing iron becomes part of ongoing care alongside the transfusions themselves: daily tablets or overnight infusions, regular blood tests and MRI scans of the liver and heart at intervals the care team sets. Keeping up with chelation is often the hardest part, especially with overnight infusions, and it matters because iron accumulates without causing symptoms until damage is under way. Before effective chelation, iron damage to the heart and hormone glands often caused death by early adulthood in people with thalassemia major. With consistent treatment and monitoring, that outlook has improved dramatically, although heart iron remains the leading cause of death in thalassemia major and iron in the liver can lead to scarring (cirrhosis) and a higher risk of liver cancer. When transfusions end, as after a successful transplant, the stored iron does not leave on its own, but it can usually be brought down over months with phlebotomy or chelation. Idiopathic pulmonary hemosiderosis tends to come in episodes of bleeding separated by quieter periods, and its course varies widely. Some people stay well for long stretches on treatment, while others have repeated flares that leave lasting scarring in the lungs. There is no known cure, but survival has improved substantially over recent decades. Follow-up with a lung specialist, with breathing tests, chest imaging and blood counts, helps catch flares and adjust treatment. In adults the condition is very rare and the first episode can be severe. Superficial siderosis is usually slowly progressive. Hearing loss and balance problems can increasingly affect daily life, so hearing support and attention to fall risk become part of care.
If you receive regular transfusions and your iron levels have not been discussed, ask whether you need monitoring. Unexplained iron-deficiency anemia, especially in a child with recurring cough or breathlessness, is worth evaluating, as is gradually worsening hearing together with unsteady walking. If you take deferiprone, contact your care team right away for fever, sore throat or other signs of infection. If you have known iron overload, contact your care team promptly about new breathlessness with ordinary activity, a racing or irregular heartbeat, or new swelling in the legs or ankles, since iron can affect the heart. Get emergency medical help right away for coughing up more than a few teaspoons of blood, or for coughing up blood together with severe shortness of breath, chest pain, dizziness or lightheadedness. For someone with known or suspected pulmonary hemosiderosis, sudden severe difficulty breathing or a pale or bluish color also needs emergency help right away, even if no blood is coughed up.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Hemosiderosis is like, what's helped you, or ask the community a question.